Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 401-990-0 | CAS number: 106990-43-6 CHIMASSORB 119; LOWILITE 19
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: information from migrated NONS file as per inquiry # [06-0000014790-71-0000], permission to refer granted by ECHA
Data source
Reference
- Reference Type:
- other: body responsible for the test
- Title:
- Unnamed
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Annex V B7
- GLP compliance:
- yes
Test material
- Reference substance name:
- N,N',N'',N'''-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine
- EC Number:
- 401-990-0
- EC Name:
- N,N',N'',N'''-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine
- Cas Number:
- 106990-43-6
- Molecular formula:
- C132H250N32
- IUPAC Name:
- N,N',N'',N'''-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine
Constituent 1
Test animals
- Species:
- other: Wistar rat, KFM Han, outbred SPF-quality
Administration / exposure
- Route of administration:
- oral: unspecified
- Details on oral exposure:
- Diet
- Duration of treatment / exposure:
- 28 days
- No. of animals per sex per dose:
- Male: 5 animals at 0mg/kg bw/day
Male: 5 animals at 33mg/kg bw/day
Male: 5 animals at 134mg/kg bw/day
Male: 5 animals at 750mg/kg bw/day
Female: 5 animals at 0mg/kg bw/day
Female: 5 animals at 35mg/kg bw/day
Female: 5 animals at 140mg/kg bw/day
Female: 5 animals at 760mg/kg bw/day
Results and discussion
Results of examinations
- Details on results:
- Clinical observations: No death occur.
Body weight gains were reduced for both sexes of group 4 (15% males and approximately 5% for females relative to respective controls)
Lab findings: Haematology: the changes observed were not considered to be significant in toxicological terms.
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
